Acquired slow-channel syndrome

被引:0
|
作者
Scola, RH [1 ]
Werneck, LC [1 ]
Iwamoto, FM [1 ]
Comerlato, EA [1 ]
Kay, CK [1 ]
机构
[1] Univ Fed Parana, Hosp Clin, Neuromuscular Disorders Div, BR-80069900 Curitiba, Parana, Brazil
关键词
electromyography; myasthenia gravis; neuromuscular junction; slow-channel syndrome;
D O I
10.1002/1097-4598(200010)23:10<1582::AID-MUS16>3.3.CO;2-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report the case of a 37-year-old man with clinical and electrophysiological features of hereditary slow-channel syndrome (SCS) and antibodies against acetylcholine receptors (AChR-Abs). He presented with weakness of shoulder and hand muscles. A supramaximal single stimulus to the motor nerves disclosed a double compound muscle action potential (CMAP). Repetitive stimulation of ulnar, suprascapular, and median nerves showed a CMAP decrement greater than 10%. The patient responded to pyridostigmine. This report confirms the importance of AChR-Ab titers in suspected cases of hereditary SCS because patients with positive AChR-Abs may have a better response to available treatments. (C) 2000 John Wiley & Sons, Inc.
引用
收藏
页码:1582 / 1585
页数:4
相关论文
共 50 条
  • [1] Acquired slow-channel syndrome: A form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel
    Wintzen, AR
    Plomp, JJ
    Molenaar, PC
    van Dijk, JG
    van Kempen, GTH
    Vos, RM
    Wokke, JHJ
    Vincent, A
    ANNALS OF NEUROLOGY, 1998, 44 (04) : 657 - 664
  • [2] Transgenic mouse model of the slow-channel syndrome
    Gomez, CM
    Bhattacharyya, BB
    Charnet, P
    Day, JW
    Labarca, C
    Wollmann, RL
    Lambert, EH
    MUSCLE & NERVE, 1996, 19 (01) : 79 - 87
  • [3] CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
    Lashley, D.
    Burke, G.
    Beeson, D.
    Jayawant, S.
    Palace, J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (11):
  • [4] Treatment of slow-channel congenital myasthenic syndrome with fluoxetine
    Harper, CM
    Fukodome, T
    Engel, AG
    NEUROLOGY, 2003, 60 (10) : 1710 - 1713
  • [5] Suggests multiple causes of weakness in slow-channel syndrome
    Gomez, CM
    Maselli, R
    Williams, JM
    Bhattacharyya, BB
    Wollmann, RL
    Day, JW
    MYASTHENIA GRAVIS AND RELATED DISEASES: DISORDERS OF THE NEUROMUSCULAR JUNCTION, 1998, 841 : 167 - 180
  • [6] Fluoxetine is neuroprotective in slow-channel congenital myasthenic syndrome
    Zhu, Haipeng
    Grajales-Reyes, Gary E.
    Alicea-Vazquez, Vivianette
    Grajales-Reyes, Jose G.
    Robinson, KaReisha
    Pytel, Peter
    Baez-Pagan, Carlos A.
    Lasalde-Dominicci, Jose A.
    Gomez, Christopher M.
    EXPERIMENTAL NEUROLOGY, 2015, 270 : 88 - 94
  • [7] Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome
    Harper, CM
    Engel, AG
    ANNALS OF NEUROLOGY, 1998, 43 (04) : 480 - 484
  • [8] Acetylcholine Receptor Gating in a Zebrafish Model for Slow-Channel Syndrome
    Walogorsky, Michael
    Mongeon, Rebecca
    Wen, Hua
    Mandel, Gail
    Brehm, Paul
    JOURNAL OF NEUROSCIENCE, 2012, 32 (23): : 7941 - 7948
  • [9] Clinical and genetic characterization of an Italian family with slow-channel syndrome
    Corrado Angelini
    Ludovico Lispi
    Cecilia Salvoro
    Maria Luisa Mostacciuolo
    Giovanni Vazza
    Neurological Sciences, 2019, 40 : 503 - 507
  • [10] Clinical and genetic characterization of an Italian family with slow-channel syndrome
    Angelini, Corrado
    Lispi, Ludovico
    Salvoro, Cecilia
    Mostacciuolo, Maria Luisa
    Vazza, Giovanni
    NEUROLOGICAL SCIENCES, 2019, 40 (03) : 503 - 507